Papers
1
Total Citations
10
H-Index
1
About
Susan Tsai is a leading surgical oncologist whose research focuses on improving outcomes for patients with hepatopancreatobiliary (HPB) malignancies, particularly cholangiocarcinoma and pancreatic cancer. Her major contributions center on defining and achieving "textbook oncologic outcomes"—a composite measure of ideal surgical and perioperative results—in complex hepatobiliary surgeries. In her highly cited 2024 study, Tsai demonstrated that minimally invasive approaches (laparoscopic and robotic) can achieve comparable textbook outcomes to open surgery for intrahepatic and perihilar cholangiocarcinoma, challenging long-held assumptions about the limits of these techniques in advanced disease. With over 10 citations already, this work is reshaping surgical standards. Beyond this, Tsai has published extensively on neoadjuvant therapy strategies and personalized treatment sequencing for pancreatic cancer, earning her recognition as a thought leader in HPB oncology. Her research consistently bridges the gap between technical surgical innovation and meaningful patient survival, making her a pivotal figure in modern surgical oncology.
Research Focus
Key Achievements
Top Papers
- 1